{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:02:11Z","timestamp":1793296931007,"version":"4.5.0"},"reference-count":194,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>Bipolar disorder (BD) is characterized by extreme mood swings ranging from manic\/hypomanic to depressive episodes. The severity, duration, and frequency of these episodes can vary widely between individuals, significantly impacting quality of life. Individuals with BD spend almost half their lives experiencing mood symptoms, especially depression, as well as associated clinical dimensions such as anhedonia, fatigue, suicidality, anxiety, and neurovegetative symptoms. Persistent mood symptoms have been associated with premature mortality, accelerated aging, and elevated prevalence of treatment-resistant depression. Recent efforts have expanded our understanding of the neurobiology of BD and the downstream targets that may help track clinical outcomes and drug development. However, as a polygenic disorder, the neurobiology of BD is complex and involves biological changes in several organelles and downstream targets (pre-, post-, and extra-synaptic), including mitochondrial dysfunction, oxidative stress, altered monoaminergic and glutamatergic systems, lower neurotrophic factor levels, and changes in immune-inflammatory systems. The field has thus moved toward identifying more precise neurobiological targets that, in turn, may help develop personalized approaches and more reliable biomarkers for treatment prediction. Diverse pharmacological and non-pharmacological approaches targeting neurobiological pathways other than neurotransmission have also been tested in mood disorders. This article reviews different neurobiological targets and pathophysiological findings in non-canonical pathways in BD that may offer opportunities to support drug development and identify new, clinically relevant biological mechanisms. These include: neuroinflammation; mitochondrial function; calcium channels; oxidative stress; the glycogen synthase kinase-3 (GSK3) pathway; protein kinase C (PKC); brain-derived neurotrophic factor (BDNF); histone deacetylase (HDAC); and the purinergic signaling pathway.<\/jats:p>","DOI":"10.3389\/fnins.2023.1228455","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T04:45:10Z","timestamp":1690865110000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder"],"prefix":"10.3389","volume":"17","author":[{"given":"Rodrigo","family":"Machado-Vieira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan C.","family":"Courtes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Carlos A.","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioline D.","family":"Henter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husseini K.","family":"Manji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pnpbp.2012.11.015","article-title":"Protein kinase C regulates mood-related behaviors and adult hippocampal cell proliferation in rats","volume":"43","author":"Abrial","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/bdi.13041","article-title":"Endoxifen: a new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder","volume":"23","author":"Ahmad","year":"2021","journal-title":"Bipolar Disord."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1399-5618.2006.00363.x","article-title":"Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial","volume":"8","author":"Akhondzadeh","year":"2006","journal-title":"Bipolar Disord."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jad.2014.11.005","article-title":"Increased uric acid levels in bipolar disorder subjects during different phases of illness","volume":"173","author":"Albert","year":"2015","journal-title":"J. Affect. Disord."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbi.2013.10.017","article-title":"NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder","volume":"36","author":"Alcocer-G\u00f3mez","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/fnins.2018.00386","article-title":"Mitochondria and mood: mitochondrial dysfunction as a key player in the manifestation of depression","volume":"12","author":"Allen","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/1028415X.2018.1544332","article-title":"Fermented foods, the gut and mental health: a mechanistic overview with implications for depression and anxiety","volume":"23","author":"Aslam","year":"2020","journal-title":"Nutr. Neurosci."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e43057","DOI":"10.1371\/journal.pone.0043057","article-title":"P2RX7: expression responds to sleep deprivation and associates with rapid cycling in bipolar disorder type 1","volume":"7","author":"Backlund","year":"2012","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"16271","DOI":"10.1038\/s41598-021-95850-6","article-title":"Vitamin D3 administration prevents memory deficit and alteration of biochemical parameters induced by unpredictable chronic mild stress in rats","volume":"11","author":"Bakhtiari-Dovvombaygi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/pcn.12518","article-title":"Purinergic dysfunction in bipolar disorder: any role for the antioxidant uric acid as a trait and state biomarker?","volume":"71","author":"Bartoli","year":"","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jpsychires.2021.09.018","article-title":"Repurposed drugs as adjunctive treatments for mania and bipolar depression: a meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials","volume":"143","author":"Bartoli","year":"","journal-title":"J. Psychiatr. Res."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1192\/j.eurpsy.2022.2340","article-title":"The association of kynurenine pathway metabolites with symptom severity and clinical features of bipolar disorder: an overview","volume":"65","author":"Bartoli","year":"2022","journal-title":"Eur. Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1192\/bjp.bp.115.180281","article-title":"Allopurinol as add-on treatment for mania symptoms in bipolar disorder: systematic review and meta-analysis of randomised controlled trials","volume":"210","author":"Bartoli","year":"","journal-title":"Br. J. Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.comppsych.2016.09.011","article-title":"Purinergic system dysfunctions in subjects with bipolar disorder: a comparative cross-sectional study","volume":"73","author":"Bartoli","year":"","journal-title":"Compr. Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1038\/s41380-020-00913-1","article-title":"The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites","volume":"26","author":"Bartoli","year":"","journal-title":"Mol. Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/j.neuropharm.2012.01.015","article-title":"Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments","volume":"62","author":"Bartzokis","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"ITC97-ITC112","DOI":"10.7326\/AITC202207190","article-title":"Bipolar disorder","volume":"175","author":"Bauer","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/npp.2012.172","article-title":"Lithium and GSK3-\u03b2 promoter gene variants influence white matter microstructure in bipolar disorder","volume":"38","author":"Benedetti","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12916-019-1257-1","article-title":"A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo","volume":"17","author":"Berk","year":"2019","journal-title":"BMC Med."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00441-014-1806-z","article-title":"Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia","volume":"357","author":"Berridge","year":"2014","journal-title":"Cell Tissue Res."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3390\/medicina55080458","article-title":"Can anhedonia be considered a suicide risk factor? A review of the literature","volume":"55","author":"Bonanni","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3233\/JAD-2010-1330","article-title":"Uric acid as a CNS antioxidant","volume":"19","author":"Bowman","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"170029","DOI":"10.1038\/sdata.2017.29","article-title":"A standard database for drug repositioning","volume":"4","author":"Brown","year":"2017","journal-title":"Sci Data"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.tips.2006.01.005","article-title":"Historical review: ATP as a neurotransmitter","volume":"27","author":"Burnstock","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"ref27","first-page":"203","article-title":"The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann. Gastroenterol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/pcn.12163","article-title":"Mitochondrial DNA variation and increased oxidative damage in euthymic patients with bipolar disorder","volume":"68","author":"Chang","year":"2014","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1028963","DOI":"10.3389\/fnmol.2022.1028963","article-title":"Inhibition of glycogen synthase kinase 3 by lithium, a mechanism in search of specificity","volume":"15","author":"Chatterjee","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/mp.2017.188","article-title":"Purinergic system in psychiatric diseases","volume":"23","author":"Cheffer","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jad.2017.09.034","article-title":"Allopurinol augmentation in acute mania: a meta-analysis of placebo-controlled trials","volume":"226","author":"Chen","year":"2018","journal-title":"J Affect Dis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1034\/j.1399-5618.2000.20303.x","article-title":"Lithium regulates PKC-mediated intracellular cross-talk and gene expression in the CNS in vivo","volume":"2","author":"Chen","year":"2000","journal-title":"Bipolar Disord."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.neuron.2014.04.003","article-title":"Calcium-dependent PKC isoforms have specialized roles in short-term synaptic plasticity","volume":"82","author":"Chu","year":"2014","journal-title":"Neuron"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.psychres.2009.07.012","article-title":"Increased risk of gout among patients with bipolar disorder: a nationwide population-based study","volume":"180","author":"Chung","year":"2010","journal-title":"Psychiatry Res."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1590\/1516-4446-2012-1693","article-title":"Bipolar disorder prevalence: a systematic review and meta-analysis of the literature","volume":"37","author":"Clemente","year":"2015","journal-title":"Braz J Psychiatry"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1136\/jnnp-2020-323632","article-title":"Primary mitochondrial diseases incrase susceptibilty to bipolar affective disorder","volume":"91","author":"Colasanti","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1016\/S0140-6736(13)60855-7","article-title":"Genetics of bipolar disorder","volume":"381","author":"Craddock","year":"2013","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/bdi.12285","article-title":"N-acetylaspartate normalization in bipolar depression after lamotrigine treatment","volume":"17","author":"Croarkin","year":"2015","journal-title":"Bipolar Disord."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"PCC.13r01609","DOI":"10.4088\/PCC.13r01609","article-title":"The diagnosis and treatment of bipolar disorder: decision-making in primary care","volume":"16","author":"Culpepper","year":"2014","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1741-7015-11-126","article-title":"Toward the future of psychiatric diagnosis: the seven pillars of RDoC","volume":"11","author":"Cuthbert","year":"2013","journal-title":"BMC Med."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1038\/s41380-023-01955-x","article-title":"Does treatment with autophagy-enhancers and\/or ROS-scavengers alleviate behavioral and neurochemical consequences of low-dose rotenone-induced mild mitochondrial dysfunction in mice?","volume":"28","author":"Damri","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"13514","DOI":"10.1021\/acs.jmedchem.0c01193","article-title":"Repurposing of drugs\u2013the ketamine story","volume":"63","author":"Das","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41398-022-02127-1","article-title":"Mitochondria DNA copy number, mitochondria DNA total somatic deletions, complex I activity, synapse number, and synaptic mitochondria number are altered in schizophrenia and bipolar disorder","volume":"12","author":"Das","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/bdi.12601","article-title":"An update on adjunctive treatment options for bipolar disorder","volume":"20","author":"Dean","year":"2018","journal-title":"Bipolar Disord."},{"key":"ref45","volume-title":"The making of DSM-III: A diagnostic Manual\u2019s conquest of American psychiatry","author":"Decker","year":"2013"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbi.2016.12.010","article-title":"The microbiome, immunity, and schizophrenia and bipolar disorder","volume":"62","author":"Dickerson","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/1570159X13666150630175841","article-title":"Future directions for pharmacotherapies for treatment-resistant bipolar disorder","volume":"13","author":"Dodd","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00429-008-0189-x","article-title":"Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression","volume":"213","author":"Drevets","year":"2008","journal-title":"Brain Struct. Funct."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"11573","DOI":"10.1073\/pnas.0913138107","article-title":"A kinesin signaling complex mediates the ability of GSK-3\u03b2 to affect mood-associated behaviors","volume":"107","author":"Du","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1242\/jeb.107086","article-title":"Epigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants","volume":"218","author":"Duclot","year":"2015","journal-title":"J. Exp. Biol."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2018.02.004","article-title":"Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment","volume":"102","author":"Edberg","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"110050","DOI":"10.1016\/j.pnpbp.2020.110050","article-title":"Drug repositioning for treatment-resistant depression: hypotheses from a pharmacogenomic study","volume":"104","author":"Fabbri","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.tics.2019.03.009","article-title":"The heterogeneity problem: approaches to identify psychiatric subtypes","volume":"23","author":"Feczko","year":"2019","journal-title":"Trends Cogn. Sci."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/mp.2013.172","article-title":"Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis","volume":"19","author":"Fernandes","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12916-015-0529-7","article-title":"Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies","volume":"13","author":"Fernandes","year":"2015","journal-title":"BMC Med."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S2215-0366(16)30370-4","article-title":"C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis","volume":"3","author":"Fernandes","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"100518","DOI":"10.1016\/j.bbih.2022.100518","article-title":"Anti-inflammatory medications for the treatment of mental disordes: a scoping review","volume":"26","author":"Fitton","year":"2022","journal-title":"Brain Behav. Immun. Health"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.biopsych.2013.03.018","article-title":"Meta-analysis of oxidative stress in schizophrenia","volume":"74","author":"Flatow","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1600-0447.2007.01069.x","article-title":"In vivo evidence for early neurodevelopmental anomaly of the anterior cingulate cortex in bipolar disorder","volume":"116","author":"Fornito","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.bbr.2011.04.022","article-title":"Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression","volume":"227","author":"Fournier","year":"2012","journal-title":"Behav. Brain Res."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pbb.2018.12.006","article-title":"Revisiting inflammation in bipolar disorder","volume":"177","author":"Fries","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.biopsych.2019.07.015","article-title":"Mesenchymal stromal cells modulate peripheral stress-induced innate immune activation indirectly limiting the emergence of neuroinflammation-driven depressive and anxiety-like behaviors","volume":"86","author":"Gallagher","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1176\/ajp.141.12.1602","article-title":"Antimanic effects of verapamil","volume":"141","author":"Giannini","year":"1984","journal-title":"Am. J. Psychiatry"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jad.2021.11.007","article-title":"What not to use in bipolar disorders: a systematic review of non-recommended treatments in clinical practice guidelines","author":"Gomes","year":"2022","journal-title":"J Affect Dis"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s40263-022-00934-0","article-title":"The purinergic system as a target for the development of treatments for bipolar disorder","volume":"36","author":"Gon\u00e7alves","year":"2022","journal-title":"CNS Drugs"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.psychres.2016.10.007","article-title":"Peripheral adenosine levels in euthymic patients with bipolar disorder","volume":"246","author":"Gubert","year":"2016","journal-title":"Psychiatry Res."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41380-020-0831-4","article-title":"Advances toward precision medicine for bipolar disorder: mechanisms and molecules","volume":"26","author":"Haggarty","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.conb.2015.07.002","article-title":"Molecular neurobiological clues to the pathogenesis of bipolar disorder","volume":"36","author":"Harrison","year":"2016","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.tins.2017.10.006","article-title":"The emerging neurobiology of bipolar disorder","volume":"41","author":"Harrison","year":"2018","journal-title":"Trends Neurosci."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0028-3908(02)00217-4","article-title":"Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity","volume":"43","author":"Hashimoto","year":"2002","journal-title":"Neuropharmacology"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s40263-021-00816-x","article-title":"Novel glutamatergic modulators for the treatment of mood disorders: current status","volume":"35","author":"Henter","year":"2021","journal-title":"CNS Drugs"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pneurobio.2015.09.002","article-title":"Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders","volume":"134","author":"Heyes","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.schres.2013.06.038","article-title":"Adenosine hypothesis in schizophrenia and bipolar disorder: a systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators","volume":"149","author":"Hirota","year":"2013","journal-title":"Schizophr. Res."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41380-021-01386-6","article-title":"Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: systematic review, meta-analysis, and rationale","volume":"27","author":"Hong","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(16)00143-4","article-title":"Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study","volume":"387","author":"Hou","year":"2016","journal-title":"Lancet"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/pcn.13433","article-title":"Pro-inflammatory cytokines and cognitive dysfunction among patients with bipolar disorder and major depression","volume":"76","author":"Huang","year":"2022","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S2215-0366(20)30138-3","article-title":"Minocycline and celecoxib as adjunctive treatments for bipolar depression: a multicentre, factorial design randomised controlled trial","volume":"7","author":"Husain","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.47626\/1516-4446-2022-2973","article-title":"The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies","volume":"26","author":"Inam","year":"2023","journal-title":"Braz J Psychiatry"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.euroneuro.2014.05.013","article-title":"In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder","volume":"24","author":"Jahangard","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1176\/ajp.155.7.972","article-title":"Verapamil for the treatment of acute mania: a double-blind, placebo-controlled trial","volume":"155","author":"Janicak","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/bdi.12980","article-title":"Oxidative stress parameters and antioxidants in patients with bipolar disorder: results from a meta-analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls","volume":"23","author":"Jim\u00e9nez-Fern\u00e1ndez","year":"2021","journal-title":"Bipolar Disord."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.coph.2009.09.002","article-title":"The role of mitochondria in health and disease","volume":"9","author":"Johannsen","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/7854_2020_157","article-title":"Intracellular signaling cascades in bipolar disorder","volume":"48","author":"Jones","year":"2020","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12929-021-00742-6","article-title":"Inflammatory signaling mechanisms in bipolar disorder","volume":"28","author":"Jones","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2174\/1389450110607011421","article-title":"Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions","volume":"7","author":"Jope","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/jphp.13273","article-title":"Drug repositioning: a brief overview","volume":"72","author":"Jourdan","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5607\/en.2014.23.1.28","article-title":"Disturbance of the glutamatergic system in mood disorders","volume":"23","author":"Jun","year":"2014","journal-title":"Exp Neurobiol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.biopsych.2017.09.010","article-title":"What can mitochondrial DNA analysis tell us about mood disorders","volume":"83","author":"Kasahara","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/pcn.12852","article-title":"Current understanding of bipolar disorder: toward integration of biological basis and treatment strategies","volume":"73","author":"Kato","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fphar.2012.00061","article-title":"Physiology and pathology of calcium signaling in the brain","volume":"3","author":"Kawamoto","year":"2012","journal-title":"Front. Pharmacol."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/s0165-0327(00)00177-4","article-title":"A review of randomized, controlled clinical trials in acute mania","volume":"59","author":"Keck","year":"2000","journal-title":"J. Affect. Disord."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1080\/1028415X.2019.1665854","article-title":"Protective effects of vitamin D on neurophysiologic alterations in brain aging: role of brain-derived neurotrophic factor (BDNF)","volume":"24","author":"Khairy","year":"2021","journal-title":"Nutr. Neurosci."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2967\/jnumed.118.216747","article-title":"18 F-JNJ-64413739, a novel PET ligand for the P2X7 ion channel: radiation dosimetry, kinetic modeling, test-retest variability, and occupancy of the P2X7 antagonist JNJ-54175446","volume":"60","author":"Koole","year":"2019","journal-title":"J. Nucl. Med."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/j.1471-4159.2005.03219.x","article-title":"Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity: antioxidant properties of minocycline","volume":"94","author":"Kraus","year":"2005","journal-title":"J. Neurochem."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jad.2016.08.046","article-title":"1H-magnetic resonance spectroscopy study of glutamate-related abnormality in bipolar disorder","volume":"208","author":"Kubo","year":"2017","journal-title":"J. Affect. Disord."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1399-5618.2007.00467.x","article-title":"Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder","volume":"9","author":"Kupka","year":"2007","journal-title":"Bipolar Disord."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.pnpbp.2006.02.002","article-title":"Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications","volume":"30","author":"Lara","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"e0133283","DOI":"10.1371\/journal.pone.0133283","article-title":"Risk of psychiatric disorders following irritable bowel syndrome: a nationwide population-based cohort study","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1038\/s41380-021-01051-y","article-title":"Peripheral inflammatory biomarkers define biotypes of bipolar depression","volume":"26","author":"Lee","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/YPG.0000000000000267","article-title":"Epigenetics in bipolar disorder: a critical review of the literature","volume":"31","author":"Legrand","year":"2021","journal-title":"Psychiatr. Genet."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1038\/s41380-021-01061-w","article-title":"Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs","volume":"26","author":"Le-Niculescu","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/npp.2010.105","article-title":"Is glycogen synthase kinase-3 a central modulator in mood regulation?","volume":"35","author":"Li","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bj.2020.01.001","article-title":"Brain-derived neurotrophic factor and mental disorders","volume":"43","author":"Lin","year":"2020","journal-title":"Biom. J."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jad.2022.06.040","article-title":"Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder\u2013a nationwide cohort study","volume":"313","author":"Lintunen","year":"2022","journal-title":"J Affect Dis"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jad.2009.05.023","article-title":"Association of serum uric acid levels with emotional and affective temperaments","volume":"121","author":"Lorenzi","year":"2010","journal-title":"J. Affect. Disord."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jad.2017.12.026","article-title":"Lithium, stress, and resilience in bipolar disorder: deciphering this key homeostatic synaptic plasticity regulator","volume":"233","author":"Machado-Vieira","year":"2018","journal-title":"J. Affect. Disord."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neulet.2007.05.016","article-title":"Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects","volume":"421","author":"Machado-Vieira","year":"2007","journal-title":"Neurosci. Lett."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1755-5949.2010.00203.x","article-title":"Histone deacetylases and mood disorders: epigenetic programming in gene-environment interactions","volume":"17","author":"Machado-Vieira","year":"","journal-title":"CNS Neurosci. Ther."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/00004714-200112000-00017","article-title":"Therapeutic efficacy of allopurinol in mania associated with hyperuricemia","volume":"21","author":"Machado-Vieira","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1054\/mehy.2001.1543","article-title":"Purinergic dysfunction in mania: an integrative model","volume":"58","author":"Machado-Vieira","year":"2002","journal-title":"Med. Hypotheses"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.biopsych.2010.10.019","article-title":"The Bcl-2 gene polymorphism rs956572AA increases inositol 1,4,5-trisphosphate receptor-mediated endoplasmic reticulum calcium release in subjects with bipolar disorder","volume":"69","author":"Machado-Vieira","year":"","journal-title":"Biol. Psychiatry"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/14737159.2017.1270758","article-title":"Convergent lines of evidence support the role of uric acid levels as a potential biomarker in bipolar disorder","volume":"17","author":"Machado-Vieira","year":"","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.4088\/JCP.v69n0806","article-title":"A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3109\/15622975.2013.830775","article-title":"Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach","volume":"15","author":"Machado-Vieira","year":"2014","journal-title":"World J. Biol. Psychiatry"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/JCP.0000000000000616","article-title":"Increased brain lactate during depressive episodes and reversal effects by lithium monotherapy in drug-naive bipolar disorder: a 3-T 1H-MRS study","volume":"37","author":"Machado-Vieira","year":"","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s40263-016-0380-1","article-title":"Therapeutic mechanisms of lithium in bipolar disorder: recent advances and current understanding","volume":"30","author":"Malhi","year":"2016","journal-title":"CNS Drugs"},{"key":"ref119","first-page":"82","article-title":"Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness","volume":"61","author":"Manji","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jad.2016.09.056","article-title":"Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: a pilot, open-label study","volume":"207","author":"Mansur","year":"2017","journal-title":"J. Affect. Disord."},{"key":"ref121","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.brainres.2005.11.061","article-title":"Effect of allopurinol on brain adenosine levels during hypoxia in newborn piglets","author":"Marro","year":"2006","journal-title":"Brain Res."},{"key":"ref122","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jpsychires.2017.07.021","article-title":"Vitamin D supplementation in bipolar depression: a double blind placebo controlled trial","volume":"95","author":"Marsh","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1038\/s41380-020-00951-9","article-title":"The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies","volume":"26","author":"Marx","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/glia.22904","article-title":"Mechanism of microglia neuroprotection: involvement of P2X7, TNF\u03b1, and valproic acid","volume":"64","author":"Masuch","year":"2016","journal-title":"Glia"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/wps.20997","article-title":"The clninical characterization of the adult patient with bipolar disorder aimed at personalization of management","volume":"21","author":"McIntyre","year":"2022","journal-title":"World Psychiatry"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","article-title":"Bipolar disorders","volume":"396","author":"McIntyre","year":"2020","journal-title":"Lancet"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/jamapsychiatry.2019.0779","article-title":"Efficacy of adjunctive infliximab vs placebo in the treatment of adults with bipolar I\/II depression: a randomized clinical trial","volume":"76","author":"McIntyre","year":"2019","journal-title":"JAMA Psychiat."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1586\/ern.12.98","article-title":"Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?","volume":"12","author":"McNamara","year":"2012","journal-title":"Expert. Rev. Neurother."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/JCP.0000000000000938","article-title":"Evaluating the effect of coenzyme Q10 augmentation on treatment of bipolar depression: a double-blind controlled clinical trial","volume":"38","author":"Mehrpooya","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature15526","article-title":"Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder","volume":"527","author":"Mertens","year":"2015","journal-title":"Nature"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0165-0327(14)70003-5","article-title":"The prevalence and burden of bipolar depression","volume":"169","author":"Miller","year":"2014","journal-title":"J. Affect. Disord."},{"key":"ref132","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"ref133","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.mrfmmm.2007.01.006","article-title":"Sequence and functional analyses of mtDNA in a maternally inherited family with bipolar disorder and depression","volume":"617","author":"Munakata","year":"2007","journal-title":"Mutat. Res."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"100","DOI":"10.9758\/cpn.2017.15.2.100","article-title":"Wnt and GSK3 signaling pathways in bipolar disorder: clinical and therapeutic implications","volume":"15","author":"Muneer","year":"2017","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.psychres.2014.11.038","article-title":"Serum uric acid levels and different phases of illness in bipolar I patients treated with lithium","volume":"225","author":"Muti","year":"2015","journal-title":"Psychiatry Res."},{"key":"ref136","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8","article-title":"Distribution of protein kinase Mzeta and the complete protein kinase C isoform family in rat brain","volume":"426","author":"Naik","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"ref137","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/jat.3093","article-title":"Ginsenoside re protects methamphetamine-induced mitochondrial burdens and proapoptosis via genetic inhibition of protein kinase C \u03b4 in human neuroblastoma dopaminergic SH-SY5Y cell lines: re protects methamphetamine toxicity by anti-apoptosis in SH-SY5Y cell","volume":"35","author":"Nam","year":"2015","journal-title":"J. Appl. Toxicol."},{"key":"ref138","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/bdi.12708","article-title":"Serum uric acid as a predictor of bipolarity in individuals with a major depressive episode","volume":"21","author":"Oliviera","year":"2019","journal-title":"Bipolar Disord."},{"key":"ref139","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1124\/pr.58.1.6","article-title":"Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"ref140","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3390\/membranes4030565","article-title":"Trafficking of kainate receptors","volume":"4","author":"Pahl","year":"2014","journal-title":"Membranes (Basel)"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jpsychires.2020.07.019","article-title":"Protein and mRNA expression of protein kinase C (PKC) in the postmortem brain of bipolar and schizophrenic subjects","volume":"130","author":"Pandey","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3389\/fnins.2018.00756","article-title":"Liraglutide activates mTORC1 signaling and AMPA receptors in rat hippocampal neurons under toxic conditions","volume":"12","author":"Park","year":"2018","journal-title":"Front. Neurosci."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1176\/appi.ajp.2010.10040541","article-title":"Genome-wide association study of suicide attempts in mood disorder patients","volume":"167","author":"Perlis","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/NMD.0000000000000425","article-title":"The burden of repeated mood episodes in bipolar I disorder: results from the National Epidemiological Survey on alcohol and related conditions","volume":"204","author":"Peters","year":"2016","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref145","doi-asserted-by":"publisher","first-page":"e805","DOI":"10.1038\/tp.2016.78","article-title":"Differential expression of transcriptional regulatory units in the prefrontal cortex of patients with bipolar disorder: potential role of early growth response gene 3","volume":"6","author":"Pfaffenseller","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fnbeh.2018.00015","article-title":"EGR3 immediate early gene and the brain-derived neurotrophic factor in bipolar disorder","volume":"12","author":"Pfaffenseller","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"ref147","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1007\/s00213-021-05789-9","article-title":"The effect of N-acetylcysteine on bipolar depression: a systematic review and meta-analysis of randomized controlled trials","volume":"238","author":"Pittas","year":"2021","journal-title":"Psychopharmacology"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pscychresns.2019.01.009","article-title":"Markers of neuroinflammation influence measures of cortical thickness in bipolar depression","volume":"285","author":"Poletti","year":"2019","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"113319","DOI":"10.1016\/j.psychres.2020.113319","article-title":"Vascular endothelial growth factor in major depressive disorder, schizophrenia, and bipolar disorder: a network meta-analysis","volume":"292","author":"Pu","year":"2020","journal-title":"Psychiatry Res."},{"key":"ref150","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/mp.2009.47","article-title":"Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients","volume":"15","author":"Rao","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/mp.2008.31","article-title":"Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?","volume":"13","author":"Rao","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1177\/0269881120914206","article-title":"Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial","volume":"34","author":"Recourt","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"ref153","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/bdi.12373","article-title":"Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis","volume":"18","author":"Rosenblat","year":"2016","journal-title":"Bipolar Disord."},{"key":"ref154","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/brainsci7110144","article-title":"Bipolar disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications","volume":"7","author":"Rosenblat","year":"2017","journal-title":"Brain Sci."},{"key":"ref155","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1038\/npp.2017.32","article-title":"Hippocampus glutamate and N-acetyl aspartate markers of excitotoxic neuronal compromise in posttraumatic stress disorder","volume":"42","author":"Rosso","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1192\/bjp.2018.144","article-title":"Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses","volume":"213","author":"Rowland","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/schbul\/sbp104","article-title":"Epigenetic mediation of environmental influences in major psychotic disorders","volume":"35","author":"Rutten","year":"2009","journal-title":"Schizophr. Bull."},{"key":"ref158","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/HRP.0000000000000006","article-title":"Factors associated with lithium efficacy in bipolar disorder","volume":"22","author":"Rybakowski","year":"2014","journal-title":"Harv. Rev. Psychiatry"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.pnpbp.2010.02.027","article-title":"Increased uric acid levels in drug-na\u00efve subjects with bipolar disorder during a first manic episode","volume":"34","author":"Salvadore","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0304-3940(02)00615-8","article-title":"Increased gray matter volume in lithium-treated bipolar disorder patients","volume":"329","author":"Sassi","year":"2002","journal-title":"Neurosci. Lett."},{"key":"ref161","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41398-017-0073-7","article-title":"Treatment of bipolar depression with minocycline and\/or aspirin: an adaptive, 2\u00d72 double-blind, randomized, placebo-controlled, phase IIA clinical trial","volume":"8","author":"Savitz","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000480349","article-title":"Role of protein kinase C in bipolar disorder: a review of the current literature","volume":"3","author":"Saxena","year":"2017","journal-title":"Mol Neuropsychiatry"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mito.2020.12.002","article-title":"Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder","volume":"57","author":"Scaini","year":"2021","journal-title":"Mitochondrion"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.neubiorev.2016.06.040","article-title":"Mitochondrial dysfunction in bipolar disorder: evidence, pathophysiology and translational implications","volume":"68","author":"Scaini","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref165","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1590\/1516-4446-2019-0732","article-title":"Neurobiology of bipolar disorders: a review of genetic components, signaling pathways, biochemical changes, and neuroimaging findings","volume":"42","author":"Scaini","year":"2020","journal-title":"Braz J Psychiatry"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.biopsych.2006.06.036","article-title":"Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse","volume":"62","author":"Schroeder","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000495658","article-title":"Novel complex interactions between mitochondrial and nuclear DNA in schizophrenia and bipolar disorder","volume":"5","author":"Schulmann","year":"2019","journal-title":"Mol Neuropsychiatry"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11920-015-0574-0","article-title":"Gastroenterology issues in schizophrenia: why the gut matters","volume":"17","author":"Severance","year":"2015","journal-title":"Curr. Psychiatry Rep."},{"key":"ref169","doi-asserted-by":"publisher","first-page":"100584","DOI":"10.1016\/j.bbih.2022.100584","article-title":"Kynurenine pathway abnormalities are state-specific but not diagnosis-specific in schizophrenia and bipolar disorder","volume":"27","author":"Skorobogatov","year":"2023","journal-title":"Brain Behav Immun Health"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1503\/jpn.190029","article-title":"CACNA1C polymorphism and brain cortical structure in bipolar disorder","volume":"45","author":"Smedler","year":"2019","journal-title":"J. Psychiatry Neurosci."},{"key":"ref171","doi-asserted-by":"publisher","first-page":"e2108768119","DOI":"10.1073\/pnas.2108768119","article-title":"Disrupted Cacna1c gene expression perturbs spontaneous Ca2+ activity causing abnormal brain development and increased anxiety","volume":"119","author":"Smedler","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref172","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0165-1781(00)00175-X","article-title":"Concurrent measures of protein kinase C and phosphoinositides in lithium-treated bipolar patients and healthy individuals: a preliminary study","volume":"95","author":"Soares","year":"2000","journal-title":"Psychiatry Res."},{"key":"ref173","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1017\/S1461145713000047","article-title":"Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder","volume":"16","author":"Soeiro-de-Souza","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref174","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbi.2021.07.014","article-title":"Peripheral levels of C-reactive protein, tumor necrosis factor-\u03b1, interleukin-6, and interleukin-1\u03b2 across the mood spectrum in bipolar disorder: a meta-analysis of mean differences and variability","volume":"97","author":"Solmi","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"ref175","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1177\/0269881118800067","article-title":"Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants","volume":"32","author":"Timmers","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"ref176","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00702-017-1817-5","article-title":"A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression","volume":"125","author":"Toniolo","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nn1659","article-title":"Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action","volume":"9","author":"Tsankova","year":"2006","journal-title":"Nat. Neurosci."},{"key":"ref178","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/B978-0-12-821398-8.00008-4","article-title":"Inflammation, stress, and gut-brain axis as therapeutic targets in bipolar disorder","volume-title":"Biomarkers in Bipolar Disorders","author":"Vaccariello","year":"2022"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"109940","DOI":"10.1016\/j.pnpbp.2020.109940","article-title":"Protein kinase C isoforms as a target for manic-like behaviors and oxidative stress in a dopaminergic animal model of mania","volume":"101","author":"Valvassori","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnmol.2012.00001","article-title":"GSK-3 and Wnt signaling in neurogenesis and bipolar disorder","volume":"5","author":"Valvezan","year":"2012","journal-title":"Front. Mol. Neurosci."},{"key":"ref181","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jnc.14841","article-title":"The role of adenosine receptors in mood and anxiety disorders","volume":"151","author":"Van Calker","year":"2019","journal-title":"J. Neurochem."},{"key":"ref182","doi-asserted-by":"publisher","first-page":"172917","DOI":"10.1016\/j.pbb.2020.172917","article-title":"HDAC inhibitors reverse mania-like behavior and modulate epigenetic regulatory enzymes in an animal model of mania induced by Ouabain","volume":"193","author":"Varela","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref183","doi-asserted-by":"publisher","first-page":"18008","DOI":"10.1038\/nrdp.2018.8","article-title":"Bipolar disorders","volume":"4","author":"Vieta","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12888-018-1717-8","article-title":"Differential mitochondrial DNA copy number in three mood states of bipolar disorder","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Psychiatry"},{"key":"ref185","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cnr.2004.09.012","article-title":"Role of intracellular calcium signaling in the pathophysiology and pharmacotherapy of bipolar disorder: current status","volume":"4","author":"Warsh","year":"2004","journal-title":"Clin. Neurosci. Res."},{"key":"ref186","doi-asserted-by":"publisher","first-page":"e0227217","DOI":"10.1371\/journal.pone.0227217","article-title":"Clinical correlates associated with the long-term response of bipolar disorder patients to lithium, valproate or lamotrigine: a retrospective study","volume":"15","author":"Woo","year":"2020","journal-title":"PLoS One"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/archgenpsychiatry.2007.43","article-title":"Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen","volume":"65","author":"Yildiz","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref188","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41398-019-0570-y","article-title":"Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses","volume":"9","author":"Yuan","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"ref189","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780199300532.003.0013","article-title":"Translating biomarkers and biomolecular treatments to clinical practice: assessment of hypothesis-driven clinical trial data","volume-title":"The bipolar book: History, neurobiology, and treatment","author":"Zanetti","year":"2015"},{"key":"ref190","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1196\/annals.1300.017","article-title":"Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system","volume":"1003","author":"Zarate","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref191","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2165\/00023210-200923070-00003","article-title":"Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder","volume":"23","author":"Zarate","year":"","journal-title":"CNS Drugs"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"569","DOI":"10.2165\/00023210-200923070-00003","article-title":"Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder","volume":"23","author":"Zarate","year":"","journal-title":"CNS Drugs"},{"key":"ref193","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1399-5618.2007.00530.x","article-title":"Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study","volume":"9","author":"Zarate","year":"2007","journal-title":"Bipolar Disord."},{"key":"ref194","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.biopsych.2005.10.021","article-title":"Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder","volume":"59","author":"Zarate","year":"2006","journal-title":"Biol. Psychiatry"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1228455\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T04:45:20Z","timestamp":1690865120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1228455\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":194,"alternative-id":["10.3389\/fnins.2023.1228455"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1228455","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]},"article-number":"1228455"}}